Kereiakes D J, Essell J H, Abbottsmith C W, Broderick T M, Runyon J P
Department of Cardiology, University of Cincinnati College of Medicine, Ohio, USA.
Am J Cardiol. 1996 Nov 15;78(10):1161-3. doi: 10.1016/s0002-9149(96)90072-7.
First-time abciximab administration was associated with acute profound thrombocytopenia in 4 of 575 consecutive patients. Therapy with platelet transfusion, but not intravenous immunoglobulin, was associated with a rapid and sustained increment in circulating platelet count and clinical hemostasis.
在连续575例患者中，有4例在首次使用阿昔单抗时出现急性严重血小板减少症。血小板输注治疗而非静脉注射免疫球蛋白治疗与循环血小板计数的快速持续增加及临床止血相关。
